Table 2.
Clinicopathological data
| Characteristic | N (%) | |
| Stage | I | 4 (6.3) |
| II | 47 (73.4) | |
| III | 8 (12.5) | |
| CD34 | low | 28 (43.8) |
| moderate | 27 (42.2) | |
| high | 9 (14.1) | |
| Histologic grade | I | 10 (16.1) |
| II | 46 (74.2) | |
| III | 6 (9.7) | |
| ER status | Positive | 38 (59.4) |
| Negative | 24 (37.5) | |
| PR status | Positive | 38 (59.4) |
| Negative | 24 (37.5) | |
| HER2 status | Positive | 29 (45.3) |
| Negative | 33 (51.6) | |
| Tumor size | <2 cm | 5 (7.8) |
| 2-5cm | 54 (84.4) | |
| Age | <40 years | 8 (12.5) |
| ≥40 years | 52 (81.3) | |
| Histological Type | aIDCA | 57 (89.1) |
| bILCA | 4 (6.3) | |
| Node status | Positive | 29 (45.3) |
| Negative | 30 (46.9) | |
| Ki67 | Positive | 10 (15.6) |
| Negative | 52 (81.3) | |
| Annexin V | Positive | 10 (20.8) |
| Negative | 38 (79.2) | |
| Subtype | luminal A | 36 (56.3) |
| luminal B | 11 (17.2) | |
| Basal Like | 13 (20.3) | |
| ERBB2 | 2 (3.1) |
aIDCA = Invasive Ductal Carcinoma.
bILCA= Invasive Lobular Carcinoma.
* Clinicopathological data of a number of patients not available.